Water Deprivation Test: Nursing Guide
The water deprivation test is a supervised inpatient endocrine protocol—not a single urine sample. With fluids withheld, nurses track weight, blood pressure, every void, and paired serum osmolality with urine osmolality while watching for intractable thirst, orthostatic symptoms, and hypernatremia. Endotext and NHS protocols stop the dehydration phase at roughly 3% weight loss, serum sodium about 146–150 mmol/L, or plasma osmolality about 295–300 mOsm/kg. A post-deprivation desmopressin phase may follow to separate central from nephrogenic diabetes insipidus—nurses focus on safety, valid timing, and escalation—not independent diagnosis from one osmolality value.
Contents
Quick Facts
Key Takeaway
A valid water deprivation study depends on supervised fluid restriction with hourly weight and void monitoring, paired serum and urine osmolality on protocol timing, and immediate stop when Endotext or institutional stop
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Timed urine cups and serum tubes per laboratory protocol
Urine osmolality containers and serum osmolality tubes per endocrine laboratory instructions—label every specimen with exact collection time
Serial timed urine voids for osmolality; paired serum osmolality and sodium during supervised fluid restriction
Each timed void volume recorded; minimum aliquot per laboratory—not specified as a single universal volume in published references
Baseline weight, serum osmolality, sodium, and urine osmolality at protocol start; then hourly weight and urine osmolality with serum osmolality and sodium commonly every 2 hours per Endotext and NHS adult protocols until stop criteria or urine concentration plateau
Complete fluid restriction (nothing by mouth) during the dehydration phase per prescriber and endocrine protocol—light meal may be allowed the evening before per some NHS instructions; no caffeine, alcohol, or smoking for 24 hours before testing when protocol requires
Send timed urine and serum specimens to the laboratory immediately when protocol requires priority analysis—document transport time and clinical urgency on labels
Supervised test spans several hours same day; individual osmolality results often return within hours depending on laboratory priority—not specified as a single universal interval in reviewed references
Endocrine or specialty chemistry laboratory—often with on-call biochemist
What is Water Deprivation Test?
Water Deprivation Test is a supervised dynamic test used when clinicians investigate hypotonic polyuria. After baseline measurements, the patient stops oral fluids while nurses monitor weight, blood pressure, heart rate, urine output, urine osmolality, serum osmolality, and serum sodium on protocol intervals. In normal physiology, dehydration raises ADH secretion and urine concentrates. In diabetes insipidus, urine stays inappropriately dilute while serum osmolality and sodium rise. Endotext notes the dehydration phase stops when urine osmolality plateaus, plasma osmolality reaches about 295–300 mOsm/kg, serum sodium reaches about 146–150 mmol/L, body weight falls more than about 3%, or the patient develops orthostatic symptoms or intractable thirst. Many protocols then give desmopressin and compare post-dose urine osmolality to distinguish central from nephrogenic diabetes insipidus. Nurses ensure one-to-one supervision, prevent undisclosed drinking, and escalate stop criteria—not independent interpretation.
Water Deprivation in Endocrine Nursing Practice
Endocrine and neurosurgical nurses support the water deprivation test when patients have confirmed hypotonic polyuria with polyuria and polydipsia after simpler causes are excluded. Endotext and official endocrine references describe it as a key step in diabetes insipidus workups when morning urine osmolality is not already concentrated enough to exclude diabetes insipidus. Typical contexts include postoperative pituitary or hypothalamic injury after brain tumor surgery, head trauma, or idiopathic hypotonic polyuria with dilute urine despite rising serum tonicity.
Nurses use intake and output monitoring, hourly weights, orthostatic vital signs, and strict fluid restriction with continuous observation for hidden oral intake. Pair each timed urine osmolality with same-interval sodium and basic metabolic panel components when ordered. After the dehydration phase, coordinate desmopressin administration and post-dose urine sampling per endocrine orders. Escalate according to facility policy when stop criteria are met or the patient shows neurologic change, hemodynamic instability, or hypernatremia symptoms.
Before starting, confirm polyuria is documented, morning urine osmolality does not already exclude diabetes insipidus per local cutoff (often above 600–750 mOsm/kg), and medicines that affect water balance are reviewed. During deprivation, enforce nothing by mouth, supervise continuously, record every void with time and volume, trend weight hourly, and stop immediately when weight loss exceeds about 3%, serum sodium or osmolality crosses protocol limits, or the patient develops orthostatic symptoms—then notify endocrinology and document paired values.
Supervised Dehydration, Hypernatremia, and Hidden Fluid Intake Safety
The highest-risk errors are unsupervised fluid restriction, missed stop criteria, and interpreting one dilute urine osmolality without paired rising serum osmolality. Undisclosed drinking invalidates the study and may mask primary polydipsia or delay safe termination when hypernatremia develops.
- Weight loss greater than about 3% or serum sodium about 146–150 mmol/L during deprivation per Endotext
- Plasma osmolality about 295–300 mOsm/kg with confusion, orthostatic symptoms, or intractable thirst
- Hidden oral or IV fluid intake during nothing-by-mouth dehydration phase
- Proceeding with full deprivation when morning urine osmolality already above 600–750 mOsm/kg excluded diabetes insipidus
Document: hourly weights, orthostatic vitals, each void time and volume, paired serum and urine osmolality, restriction deviations, stop-criteria notification, and desmopressin timing if given.
What Water Deprivation Testing Can and Cannot Confirm
This test can help identify:
- Failure to concentrate urine during supervised dehydration when serum osmolality rises
- Central versus nephrogenic diabetes insipidus patterns after desmopressin per Endotext and NHS protocols
- Primary polydipsia features when serum osmolality stays low-normal with polyuria
- Need to stop or repeat testing when protocol deviation or stop criteria occur
This test cannot:
- Diagnose pituitary anatomy or tumor extent without imaging and specialist assessment
- Replace confirmatory copeptin or other newer pathways where institutional policy uses them
- Be interpreted from one urine osmolality without serial paired serum data and supervision context
- Be applied safely without continuous nursing observation and stop-criteria monitoring
Pre-test Checks Before Supervised Water Deprivation
Verify
Clarify before proceeding when:
- Polyuria not quantified or alternative causes not addressed
- Spot urine already concentrates enough to exclude diabetes insipidus
- Patient cannot remain under continuous observation
- Pregnancy or hemodynamic instability makes dehydration unsafe without specialist plan
- Active desmopressin or diuretic therapy without hold instructions
- Laboratory cannot process timed stat osmolality specimens
- Patient history suggests primary polydipsia with low serum osmolality—confirm endocrine indication
Dehydration-Phase and Post-Desmopressin Response Patterns
Endotext and NHS tables summarize dehydration-phase and post-desmopressin patterns. Nurses communicate paired trends and stop points—endocrinology interprets subtype labels.
| Pattern (nursing summary) | What nurses watch | Action |
|---|---|---|
| Urine osm >600–750 mOsm/kg during deprivation | Concentrating ability preserved per many protocols | Communicate stop point; diabetes insipidus unlikely—document prescriber decision |
| Low urine osm with rising serum osm | Diabetes insipidus dehydration-phase pattern | Monitor stop criteria; notify endocrine; prepare desmopressin phase if ordered |
| Urine osm rises >50% after desmopressin | Central diabetes insipidus pattern per Endotext summaries | Document post-dose times; monitor for hyponatremia after fluids allowed |
| Minimal urine rise after desmopressin | Nephrogenic diabetes insipidus pattern per protocol | Notify endocrine; continue safety monitoring—do not label independently |
| Low serum osm with polyuria | Primary polydipsia consideration per Endotext | Strict intake observation; notify prescriber—avoid unnecessary dehydration |
Water Deprivation in Inpatient Endocrine Pathways
Diagnostic safety badge: High-risk diagnostic protocol — extra safety checks required for supervised dehydration, stop criteria, and desmopressin phases.
Check-before-test protocol
- Polyuria documented and screening labs reviewed
- Morning urine osmolality checked against local exclusion cutoff
- Medicine and caffeine or alcohol restrictions confirmed
- Baseline weight, vitals, and one-to-one supervision assigned
- Stop-criteria worksheet and laboratory stat pathway confirmed
Critical teach-back questions
- “Can you tell me why you cannot drink anything during this part of the test?”
- “What symptoms—dizziness, confusion, extreme thirst—should you report immediately?”
- “Why will staff weigh you and collect every urine sample on the clock?”
Care coordination: endocrinology, neurosurgery when postoperative, biochemistry laboratory, pharmacy for desmopressin, and rapid response per institutional protocol when stop criteria or hypernatremia symptoms occur.
Why Water Deprivation Test is Ordered
Water deprivation testing is ordered when hypotonic polyuria persists and clinicians need to differentiate diabetes insipidus from primary polydipsia—or central from nephrogenic diabetes insipidus after the dehydration phase.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Suspected diabetes insipidus after initial screening | Does the patient fail to concentrate urine when serum osmolality rises? | Endotext and official endocrine references use supervised dehydration with serial osmolality when simpler studies leave hypotonic polyuria unexplained. |
| Differentiate central versus nephrogenic diabetes insipidus | Does urine concentrate after desmopressin when it stayed dilute during deprivation? | Endotext and NHS protocols add desmopressin after the dehydration phase—central diabetes insipidus typically shows a marked urine osmolality rise; nephrogenic forms show minimal response per reviewed references. |
| Evaluate primary polydipsia in the differential | Is low or normal serum sodium/osmolality with polyuria explained by excess water intake? | Endotext notes low-normal serum sodium and plasma osmolality may suggest primary polydipsia rather than diabetes insipidus—interpret with supervised observation. |
| Post-neurosurgical or pituitary pathway polyuria | Is new hypotonic polyuria after cranial surgery consistent with central diabetes insipidus? | Endotext describes inpatient supervised testing when postoperative diabetes insipidus is suspected—nurses monitor neurologic status alongside osmolality trends. |
Contraindications and Precautions
Water deprivation is contraindicated or unnecessary when the kidneys already demonstrate adequate concentrating ability. NHS protocols cite spot or morning urine osmolality above about 600–750 mOsm/kg as sufficient to exclude diabetes insipidus without full deprivation. Relative contraindications include inability to cooperate, unsafe unsupervised setting, pregnancy (special caution per Endotext), and clinical instability where dehydration poses unacceptable risk—defer and clarify with endocrinology.
- Body weight loss greater than about 3% of baseline per Endotext and NHS stop rules
- Serum sodium about 146–150 mmol/L or plasma osmolality about 295–300 mOsm/kg per Endotext stop criteria—or earlier per institutional protocol
- Orthostatic hypotension, dizziness, intractable thirst, neurologic change, or undisclosed fluid intake discovered during supervision
- Diuretics, lithium, and desmopressin alter water balance—document all medicines and follow endocrine hold guidance only; never stop prescriptions without authorization
- Caffeine, alcohol, and smoking may affect protocol validity—NHS instructions often prohibit them for 24 hours before testing
- Unsupervised or incomplete void collection invalidates serial urine osmolality trends
- Stop-criteria met with rising serum osmolality or sodium—notify endocrine prescriber and implement protocol stop orders
- Hypernatremia symptoms, confusion, seizure risk, or hemodynamic instability during deprivation
- Suspected undisclosed drinking or broken fluid restriction—notify prescriber before interpreting results as confirming or excluding diabetes insipidus
Prep That Keeps the Dehydration Phase Valid
Preparation includes confirming indication, reviewing contraindicating morning urine osmolality, medicine and caffeine or alcohol restrictions, baseline weight and labs, one-to-one supervision plan, and emergency fluid replacement readiness per protocol.
Pre-test checksReview diuretics, lithium, carbamazepine, and desmopressin or vasopressin therapy with endocrinology—follow explicit hold and restart instructions only. Document caffeine, alcohol, and nicotine use because NHS protocols often restrict them before testing. Never adjust prescription medicines without prescriber authorization.
Where the test is performed
This page is a Tests & Diagnostics guide for Water Deprivation Test. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Water Deprivation Test is a supervised inpatient endocrine protocol performed in hospital endocrine day units or specialty wards with one-to-one nursing and prescriber attendance. Nurses focus on verified fluid restriction, hourly weight and orthostatic vital monitoring, timed urine and serum osmolality specimens, stop-criteria escalation at about 3% weight loss or hypertonic serum thresholds, desmopressin phase coordination when ordered, and prevention of undisclosed fluid intake — not independent subtype diagnosis from a single osmolality value.
Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation — not equipment operation or departmental imaging protocols.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Interpreting Osmolality During Water Deprivation
Interpretation uses serial urine osmolality paired with serum osmolality and sodium during supervised deprivation, optional post-desmopressin urine osmolality, and protocol stop points. Thresholds vary by institution (for example NHS uses urine osmolality above 600 mOsm/kg to exclude diabetes insipidus; Endotext cites plateaus and percentage desmopressin responses). Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Urine osmolality rises appropriately during deprivation with serum osmolality increase; morning urine above 600–750 mOsm/kg may exclude diabetes insipidus without full test per NHS and Endotext | Preserved concentrating ability—diabetes insipidus unlikely when protocol criteria met | Communicate paired values to endocrinology; document stop point; avoid labeling diabetes insipidus when urine concentrated appropriately |
| Borderline / near reference limit | Urine osmolality plateau near institutional cutoff (for example 300–600 mOsm/kg) with rising serum osmolality | Partial concentrating response or incomplete deprivation—may proceed to desmopressin phase per prescriber or repeat with stricter supervision | Notify endocrinology; verify void timing and restriction adherence; continue monitoring per protocol |
| High / above reference interval | Not applicable as primary urine pattern—focus is inappropriately low urine osmolality during rising serum osmolality | High serum osmolality with concentrated urine suggests appropriate ADH response—not typical diabetes insipidus dehydration-phase pattern | Support prescriber interpretation; document paired trends; evaluate primary polydipsia or other causes |
| Low / below reference interval | Urine osmolality below about 300–400 mOsm/kg with serum osmolality rising during deprivation per Endotext and NHS summaries | Failure to concentrate urine despite hypertonic serum—diabetes insipidus pattern when renal tubular disease excluded | Stop or proceed to desmopressin phase per protocol; notify endocrinology; monitor for hypernatremia; document exact times and volumes |
Dehydration Stop Criteria and Hypernatremia Escalation
Universal critical-value thresholds for mid-test osmolality are not standardized in reviewed NIH and Endotext references. Urgent nursing action follows institutional stop rules—weight loss about 3%, serum sodium about 146–150 mmol/L, plasma osmolality about 295–300 mOsm/kg, orthostatic symptoms, or neurologic change—and local hypernatremia escalation policy.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Stop-criteria weight loss during deprivation | Greater than about 3% body weight loss from baseline per Endotext and NHS protocols | Stop dehydration phase per protocol; notify endocrinology; monitor vitals; prepare ordered fluids or desmopressin phase |
| Rising serum sodium or osmolality with symptoms | Serum sodium about 146–150 mmol/L or plasma osmolality about 295–300 mOsm/kg with confusion, weakness, or orthostatic vitals per Endotext | Escalate according to facility policy; stop fluid restriction; implement prescriber hypernatremia management; document paired urine osmolality |
| Broken fluid restriction | Patient drank fluids secretly or received unscheduled oral or IV hypotonic fluids during deprivation | Notify prescriber; document deviation; do not interpret test as valid without repeat per endocrine plan |
Stop the dehydration phase and escalate according to facility policy when stop criteria are met, the patient develops neurologic or hemodynamic instability, hypernatremia symptoms appear, or undisclosed fluid intake invalidates the study—regardless of a prior mid-range osmolality value.
What Invalidates a Water Deprivation Study
Water deprivation validity depends on supervision, timed specimens, medicine effects, and adherence to fluid restriction—not a single end-point urine value alone.
- Labeling diabetes insipidus when the patient drank fluids during restriction—dilute urine from intake rather than ADH deficiency
- Proceeding with full deprivation when morning urine already above 600–750 mOsm/kg excluded diabetes insipidus
- Interpreting one low urine osmolality without paired rising serum osmolality trend
- Stopping too early before plateau or stop criteria—missing diagnostic information
- Primary polydipsia with dilute serum misclassified without supervised intake observation
- Continued desmopressin therapy blunting dehydration-phase response
- Undisclosed oral or IV fluid intake during restriction
- Diuretics, lithium, or recent desmopressin exposure
- Missed or mis-timed void osmolality specimens
Endotext and peer-reviewed reviews note water deprivation plus desmopressin has imperfect sensitivity and specificity—especially for primary polydipsia—and is not routine in pregnancy without specialist oversight. The test cannot replace clinical assessment, imaging of pituitary pathology, or newer copeptin-based pathways where available. Nurses support safe execution and accurate timing—not subtype diagnosis alone.
Nursing Duties During Supervised Water Deprivation
Nursing responsibilities center on one-to-one supervision, stop-criteria monitoring, specimen timing, and prescriber communication during a high-risk dehydration protocol.
Before the TestCharting Weights, Voids, and Stop Criteria
Documentation must prove supervised restriction, specimen times, stop-criteria monitoring, and prescriber notification.
“Water deprivation day 1: baseline weight 78.2 kg at 0800; NPO fluids started 0900 after bladder empty. 1000 urine osm 310 mOsm/kg (280 mL); serum osm 292 mOsm/kg, Na+ 142 mmol/L. 1100 weight 77.9 kg; urine osm 295 mOsm/kg. 1200 prescriber notified—weight loss 0.4%, continued per endocrine protocol. 1300 nurse observed patient with water cup—test paused, endocrine fellow notified, restriction restarted after teaching. Post-desmopressin 1600: urine osm 680 mOsm/kg at +2 h—specimens labeled with exact times; evaluate outcomes at 1800 with improved thirst and stable orthostatics.”
- Baseline and hourly weights with percent change calculation
- Each void time, volume, and urine osmolality with serum pairing times
- Stop-criteria values, symptoms, and prescriber notification with read-back
- Fluid restriction start and any deviation (oral, IV, ice chips)
- Desmopressin dose, route, time, and post-dose urine osmolality schedule
- Patient tolerance, orthostatic vitals, and follow-up plan
Teaching Patients About the Water Deprivation Protocol
Use clear language about why fluids are withheld, how long supervision lasts, and symptoms that require immediate reporting.
Water Deprivation Test NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Water Deprivation Test safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Water deprivation test — supervised NPO dehydration phase; serial urine osmolality; serum osmolality and sodium q2h; desmopressin phase if ordered
- Indication: Post–transsphenoidal surgery hypotonic polyuria; endocrine consult active
- Timing: Dehydration phase hour 5 of 8; last serum draw 30 minutes ago
- Related orders: Hourly weights; orthostatic vitals; strict I&O; stop if weight loss >3% or serum osm >300 mOsm/kg; desmopressin 2 µg IM if urine osm <600 mOsm/kg at end phase
- Result: Weight −2.8% from baseline; urine osm 265 mOsm/kg (last void); serum osm 298 mOsm/kg; Na+ 147 mmol/L; prior hour urine osm 255 mOsm/kg
- Trend / prior value: Urine osmolality flat 250–270 mOsm/kg over 3 hours while serum osmolality rose from 284 to 298 mOsm/kg; weight trending down each hour
- Pending tests: Desmopressin phase not yet given; endocrine fellow due to review stop criteria
- Vital signs: HR 102/min, BP 108/62 mmHg supine to 92/58 mmHg standing, RR 18/min, SpO₂ 97% room air
- Symptoms: Marked thirst, mild dizziness when standing—no seizure activity
- Focused assessment: Dry mucous membranes; capillary refill 3 s; urine output 350–420 mL/h; oriented but irritable from thirst
- Preparation notes: NPO since 0900; caffeine withheld 24 h; home desmopressin held per endocrine protocol; baseline weight documented
- Collection events: Every void measured; 1300 urine cup found in bedside drawer—patient admitted sipping; event documented and endocrine notified
- Teaching gaps / safety concerns: Rising serum osmolality and sodium with persistently dilute urine, orthostatic BP change, weight loss nearing 3%, and prior undisclosed fluid intake
Answer key & rationale
Frequently Asked Questions
FAQ
Why is the water deprivation test performed?
Endotext and official endocrine references describe it to evaluate hypotonic polyuria when clinicians need to differentiate diabetes insipidus from primary polydipsia and, with a desmopressin phase, central from nephrogenic diabetes insipidus.
When should the dehydration phase stop?
Endotext lists stop points including urine osmolality plateau, plasma osmolality about 295–300 mOsm/kg, serum sodium about 146–150 mmol/L, greater than about 3% weight loss, orthostatic symptoms, or intractable thirst—follow exact institutional protocol.
Can diabetes insipidus be excluded without the full test?
NHS protocols note morning or spot urine osmolality above about 600–750 mOsm/kg often excludes diabetes insipidus without proceeding to full deprivation—verify local cutoff.
What does desmopressin add after water deprivation?
Endotext and NHS protocols use desmopressin after the dehydration phase—a marked rise in urine osmolality suggests central diabetes insipidus, while minimal response suggests nephrogenic diabetes insipidus per institutional interpretation rules.
Is the test safe to perform without continuous nursing supervision?
No. Endotext emphasizes adequate supervision to prevent undisclosed drinking and to monitor stop criteria. It is typically an inpatient supervised protocol with one-to-one nursing.
What medicines should be reviewed beforehand?
Review diuretics, lithium, desmopressin, and other drugs affecting water balance with endocrinology. NHS protocols also restrict caffeine, alcohol, and smoking for 24 hours when required—never stop prescriptions without prescriber guidance.
Does one low urine osmolality diagnose diabetes insipidus type?
No. Interpretation requires serial paired serum and urine osmolality during supervised deprivation and often post-desmopressin comparison. Endotext notes test limitations and imperfect accuracy—especially for primary polydipsia.
References
References
-
Fenske W; et al. Diagnostic Tests for Diabetes Insipidus. Endotext. NCBI Bookshelf.https://www.ncbi.nlm.nih.gov/books/NBK537591/
-
National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Insipidus — Diagnosis. NIH.https://www.niddk.nih.gov/health-information/kidney-disease/diabetes-insipidus/diagnosis
-
Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Deprivation Test and Desmopressin Test in Adults. Clinical Biochemistry.https://www.nbt.nhs.uk/sites/default/files/Water%20Deprivation%20Test%20in%20Adults.pdf
-
Christ-Crain M; et al. Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management. J Clin Endocrinol Metab. 2021.https://pmc.ncbi.nlm.nih.gov/articles/PMC7996474/
-
Manchester University NHS Foundation Trust. Water Deprivation Test — Adults. Endocrine testing protocol.https://mft.nhs.uk/app/uploads/2023/03/Water-deprivation-test-Adults.pdf
-
U.S. National Library of Medicine. Osmolality Tests. MedlinePlus.https://medlineplus.gov/lab-tests/osmolality-tests/
-
U.S. National Library of Medicine. Diabetes Insipidus. MedlinePlus.https://medlineplus.gov/ency/article/000377.htm
-
National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Insipidus. NIH.https://www.niddk.nih.gov/health-information/kidney-disease/diabetes-insipidus
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Water Deprivation Test.
Policies: Medical Review Process · Editorial Policy · Correction Policy